Sanofi India share price gained up to 6% in morning trades on Friday post Q4 results announced by the company after the ...

Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...

With a market valuation of Rs 11,574.76 Cr, Sanofi Indias shares ended Fridays trading session on the BSE 0.58% higher at Rs ...

KYMR reports a wider-than-expected loss for the fourth quarter of 2024. The company expects the current cash balance to provide a runway into mid-2027.

Gain insights into Recursion Pharmaceuticals' Q4 2024 earnings call. Discover clinical advancements, key partnerships, and strategic plans for 2025.

Tryn Stimart; Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer; Abcellera Biologics Inc. Carl L. Hansen; CEO, President & Chairper ...

DIsney says it has sold out all commercial inventory for Sunday's Oscars, and notes packages include TV, streaming, social ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...

Multibagger stock Vantage Knowledge Academy Limited hits upper circuit after setting record date for 2:1 bonus shares. The ...

There could be continued earnings momentum in railway, infrastructure and capital good stocks but outlook on new orders could ...

Fresh inflation data showed the Federal Reserve’s preferred gauge, the personal consumption expenditures (PCE) price index, ...

Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 11,666.74 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments ...